Yvonne Martin
Yvonne Martin
Senior Volwiler Research Felllow, Abbott Laboratories (Retired) Volunteer, Neglected Diseases
Bestätigte E-Mail-Adresse bei abbvie.com
Titel
Zitiert von
Zitiert von
Jahr
A general and fast scoring function for protein− ligand interactions: a simplified potential approach
I Muegge, YC Martin
Journal of medicinal chemistry 42 (5), 791-804, 1999
11751999
QSAR modeling: where have you been? Where are you going to?
A Cherkasov, EN Muratov, D Fourches, A Varnek, II Baskin, M Cronin, ...
Journal of medicinal chemistry 57 (12), 4977-5010, 2014
10252014
Do structurally similar molecules have similar biological activity?
YC Martin, JL Kofron, LM Traphagen
Journal of medicinal chemistry 45 (19), 4350-4358, 2002
8612002
Use of structure− activity data to compare structure-based clustering methods and descriptors for use in compound selection
RD Brown, YC Martin
Journal of chemical information and computer sciences 36 (3), 572-584, 1996
7511996
Quantitative drug design: a critical introduction
YC Martin
CRC Press, 2010
7192010
3D QSAR in drug design: volume 1: theory methods and applications
H Kubinyi
Springer Science & Business Media, 1993
4951993
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists
YC Martin, MG Bures, EA Danaher, J DeLazzer, I Lico, PA Pavlik
Journal of computer-aided molecular design 7 (1), 83-102, 1993
4881993
The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding
RD Brown, YC Martin
Journal of Chemical Information and Computer Sciences 37 (1), 1-9, 1997
4421997
3D database searching in drug design
YC Martin
Journal of Medicinal Chemistry 35 (12), 2145-2154, 1992
3971992
A bioavailability score
YC Martin
Journal of medicinal chemistry 48 (9), 3164-3170, 2005
3442005
Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
MA Abreo, NH Lin, DS Garvey, DE Gunn, AM Hettinger, JT Wasicak, ...
Journal of medicinal chemistry 39 (4), 817-825, 1996
2891996
A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry
YC Martin
Journal of medicinal chemistry 24 (3), 229-237, 1981
2591981
ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional …
JH Van Drie, D Weininger, YC Martin
Journal of Computer-Aided Molecular Design 3 (3), 225-251, 1989
2391989
3D QSAR in drug design: recent advances
H Kubinyi, G Folkers, YC Martin
Springer Science & Business Media, 2006
2042006
Let’s not forget tautomers
YC Martin
Journal of computer-aided molecular design 23 (10), 693, 2009
1882009
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein
I Muegge, YC Martin, PJ Hajduk, SW Fesik
Journal of medicinal chemistry 42 (14), 2498-2503, 1999
1821999
Quantitative structure-activity relationships of drugs
J Topliss
Elsevier, 2012
1732012
Advances in Quantative Structure-Property Relationships
M Charton
Elsevier, 2002
165*2002
Designing combinatorial library mixtures using a genetic algorithm
RD Brown, YC Martin
Journal of medicinal chemistry 40 (15), 2304-2313, 1997
1441997
Application of belief theory to similarity data fusion for use in analog searching and lead hopping
SW Muchmore, DA Debe, JT Metz, SP Brown, YC Martin, PJ Hajduk
Journal of chemical information and modeling 48 (5), 941-948, 2008
1422008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20